Heart gene bank launched: 9,880 patients enrolled to unlock secrets of coronary artery disease

NCT ID NCT00590200

Ongoing Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a large gene bank by collecting blood samples and health information from nearly 10,000 people who have had heart catheterization or cardiac CT scans. The goal is to identify genetic and other factors that contribute to coronary artery disease. Participants provide a blood sample and answer questions about their medical history. No new treatments are being tested; this is purely a research effort to better understand the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help researchers identify genetic factors linked to heart disease, potentially pointing toward new ways to predict or treat it.
What could go wrong: This is an observational study that does not test any treatment. It may take years to yield useful insights, and the findings might not lead directly to new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder myocardial infarction ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES

More trials for these conditions

Other studies related to the condition(s) this trial covers.